title: Cardiovascular safety evaluation in the development of new drugs for diabetes mellitus.
authors: From the Robert & Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH.
authors: Venu
authors: V
authors: Menon
authors: From the Robert & Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH. lincofa@ccf.org.
authors: A Michael
authors: AM
authors: Lincoff
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic / Q000639:trends; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004341:Drug Evaluation / Q000639:trends*; D023381:Endpoint Determination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D015995:Prevalence; D016730:Program Development; D012307:Risk Factors
chemical_list: D007004:Hypoglycemic Agents
keywords: United States Office of National Drug Control Policy; coronary disease; diabetes mellitus